# EDGAR Filing Document

**Accession Number:** 0001700800
**File Stem:** 0001213900-23-022816
**Filing Date:** 2023-3
**Character Count:** 2798
**Document Hash:** 4597ab7992907e3b4911a6864d50e5b7
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-23-022816.hdr.sgml**: 20230324

**ACCESSION NUMBER**: 0001213900-23-022816

**CONFORMED SUBMISSION TYPE**: 1-U

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230317

**ITEM INFORMATION**: Other Events

**FILED AS OF DATE**: 20230324

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Emerald Health Pharmaceuticals Inc.
- **CENTRAL INDEX KEY:** 0001700800
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 820669961
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 1-U
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 24R-00152
- **FILM NUMBER:** 23760163

**BUSINESS ADDRESS:**
- **STREET 1:** 5910 PACIFIC CENTER BLVD
- **STREET 2:** SUITE 320,
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92121
- **BUSINESS PHONE:** (858) 352-0622

**MAIL ADDRESS:**
- **STREET 1:** 5910 PACIFIC CENTER BLVD
- **STREET 2:** SUITE 320,
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92121

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 1-U**

**CURRENT REPORT PURSUANT TO REGULATION A**

Date of Report (Date of earliest event reported): **March 17, 2023**

**Emerald Health Pharmaceuticals Inc.**

(Exact name of issuer as specified in its charter)

**Delaware**

State or other jurisdiction of incorporation or organization

**82-0669961**

(I.R.S. Employer Identification No.)

**5910 Pacific Center Blvd., Suite 320, San Diego, CA 92121**

(Full mailing address of principal executive offices)

**(858) 352 - 0622**

(Issuer's telephone number, including area code)

**Common stock, par value $0.0001**

(Title of each class of securities issued pursuant to Regulation A)

**Item 9. Other Events**

On March 17, 2023, Emerald Health Therapeutics, Inc. (the "Company") filed a certificate of dissolution with the Delaware secretary of state and officially dissolved. The Company is in the process of winding down and liquidating pursuant to the Plan of Liquidation and Dissolution approved by the Company's Board of Directors and the Company's stockholders.

As of the date of this report, the Company's liabilities greatly exceed its cash balance and thus the Company does not anticipate there to be any assets immediately available for distribution to its stockholders.

**SIGNATURES**

Pursuant to the requirements of Regulation A, the issuer has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | |
|:---|:---|
| **EMERALD HEALTH PHARMACEUTICALS INC.,** | **EMERALD HEALTH PHARMACEUTICALS INC.,** |
| a Delaware corporation | a Delaware corporation |
| By: | */s/ Joe Lugo* |
|  | Joe Lugo |
|  | Interim CEO |

---

Date: March 24, 2023